Therapeutic Plasmapheresis Enabling Radioactive Iodine Treatment in a Patient with Thyrotoxicosis

다국어 초록 (Multilingual Abstract)

Therapeutic plasma exchange (TPE) is one possible treatment for patients resistant to conventional antithyroid drugs or requiring urgent attention for thyrotoxicosis. We report a 35-yr-old man with thyrotoxicosis, ultimately attributed to Graves’ disease in whom antithyroid drug used initially was soon discontinued, due to abnormal liver function, and replaced by Lugol’s solution. Three weeks later, an escape phenomenon (to Lugol’s solution) was apparent, so we performed TPE to control the thyrotoxicosis. Two courses of TPE by a centrifugal type machine resulted in diminished levels of thyroid hormone levels, which then rebounded after another two courses of membrane filtration type TPE. However, the patient could be treated with radioactive iodine therapy without any complications at present.

참고문헌 (Reference)

1 Genovese BM, "What is the best definitive treatment for Graves’ disease? A systematic review of the existing literature" 20 : 660-667, 2013

2 Lazarus JH, "Treatment of thyrotoxicosis with lithium carbonate" 2 : 1160-1163, 1974

3 Ashkar FS, "Thyroid storm treatment with blood exchange and plasmapheresis" 214 : 1275-1279, 1970

4 Mokrzycki MH, "Therapeutic plasma exchange : complications and management" 23 : 817-827, 1994

5 Keklik M, "The results of therapeutic plasma exchange in patients with severe hyperthyroidism : a retrospective multicenter study" 48 : 327-330, 2013

6 Houghton SG, "Surgical management of amiodarone-associated thyrotoxicosis : Mayo Clinic experience" 28 : 1083-1087, 2004

7 Lew WH, "Successful preoperative treatment of a Graves’ disease patient with agranulocytosis and hemophagocytosis using double filtration plasmapheresis" 26 : 159-161, 2011

8 Miljić D, "Role of plasma exchange in autoimmune hyperthyroidism complicated by severe tiamazol-induced cholestatic jaundice" 49 : 354-356, 2013

9 Pasimeni G, "Refractory thyrotoxicosis induced by iodinated contrast agents treated with therapeutic plasma exchange. A case report" 23 : 92-95, 2008

10 Ezer A, "Preoperative therapeutic plasma exchange in patients with thyrotoxicosis" 24 : 111-114, 2009

11 Fisher JN, "Management of thyrotoxicosis" 95 : 493-505, 2002

12 Bahn RS, "Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists" 17 : 456-520, 2011

13 Cooper DS, "Hyperthyroidism" 362 : 459-468, 2003

14 Aydemir S, "Fulminant hepatic failure associated with propylthiouracil : a case report with treatment emphasis on the use of plasmapheresis" 20 : 235-238, 2005

15 Ward DM, "Conventional apheresis therapies : a review" 26 : 230-238, 2011

16 Bogazzi F, "Comparison of radioiodine with radioiodine plus lithium in the treatment of Graves’ hyperthyroidism" 84 : 499-503, 1999

17 Venkataraman R, "Clinical review : extracorporeal blood purification in severe sepsis" 7 : 139-145, 2003